Complex Regional Pain Syndrome clinical trials at UCSF
1 in progress, 1 open to new patients

  • TARGET Post-Approval Study

    open to eligible people ages 22-75

    The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.

    San Francisco, California and other locations

© The Regents of the University of California